Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 4 , Pages 601-613, August 2008

Androgens and prostate cancer risk

  • Pär Stattin, MD, PhD (Consultant in Urology, Associate Professor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +46 90 785 22 91; Fax: +46 90 12 53 96.

Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, SE-901 85 Umeå, Sweden

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(08)00077-8

doi:10.1016/j.beem.2008.06.002

Refers to corrigendum:

  • Corrigendum to “Androgens and prostate cancer” [Best Practice & Research Clinical Endocrinology & Metabolism 2008; 22 (4): 601–613]

    Sara Wirén, Par Stattin
    Best Practice & Research Clinical Endocrinology & Metabolism February 2009 (Vol. 23, Issue 1, Page 145)

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 4 , Pages 601-613, August 2008

Article Tools

* Image Usage & Resolution